Training, guideline access and knowledge of antiretroviral interactions: Is the South African private sector being left behind?
Background. South Africa (SA) has the largest antiretroviral therapy programme in the world. While the majority of the country accesses healthcare in the public sector, 15.2% access private healthcare. In 2019, dolutegravir was introduced as first-line treatment for HIV. Dolutegravir has clinically...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
South African Medical Association
2022-10-01
|
| Edice: | South African Medical Journal |
| Témata: | |
| On-line přístup: | https://samajournals.co.za/index.php/samj/article/view/263 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|